SuperSonic Imagine is a French-based startup that specializes in ultrasound medical imaging. Founded in 2005, the company has gained recognition for its flagship product, the SuperSonic™ series, which incorporates the exclusive UltraFast™ technology. This innovative technology has led to the development of new imaging modes, particularly the groundbreaking ShearWave™ Elastography (SWE™), which allows physicians to analyze tissue stiffness, a crucial factor in diagnosing various conditions. With over 2,000 ultrasound systems installed in more than 80 countries, their main growth markets are in China, the U.S., and the E.U. Moreover, the company has received a €12.00M post-IPO equity investment at 17 December 2018 from Kreos Capital. Through its extensive network and industry engagement, SuperSonic Imagine offers a platform for professionals to connect with industry leaders and stay updated on the latest trends in ultrasound innovation and solutions. Evidenced by the 600 published articles validating the diagnostic value of their technology, the company has proved its impact in the medical imaging space. The Aixplorer MACH® 30 ultrasound diagnostic system and transducers have received the necessary certifications for various medical applications and are aimed to be used by licensed personnel qualified to direct the use of medical ultrasound devices. Overall, SuperSonic Imagine's focus on innovation and its track record of installations and investments position it as a noteworthy player in the field of medical imaging, with the potential for further growth and impact in the healthcare industry.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Post-IPO Equity | €12.00M | 1 | 17 Dec 2018 | |
Post-IPO Debt | €2.00M | 1 | 17 Dec 2018 | |
Venture Round | €5.00M | 1 | 10 Jan 2014 | |
Private Equity Round | €28.00M | 9 | NBGI Ventures, Kuwait Life Sciences Company +2 | 02 Apr 2013 |
Series C | €34.50M | 7 | NBGI Ventures | 29 Nov 2010 |
No recent news or press coverage available for SuperSonic Imagine.